Below you will find electronic versions of the latest Angle issues. To subscribe for the hard-copy version of Angle, please fill in the sign-up form.
Angle April 2013. Risky business
Compliance is a must-have in pharmaceutical production, but it is also a challenge and, right now, increasingly so. Fundamental regulatory philosophies are changing towards increased harmonisation. Regulators in Europe, the USA and Japan are all focusing on product and process understanding and want to see more scientific and statistical data rather than the traditional ‘piles of papers’.
View as eBook | Download as PDF
Angle November 2012. Injecting new hope
Despite their impact, vaccines have generally received less attention than the wider pharmaceutical market. However, this is changing – new opportunities, challenges and debates have pushed vaccines and immunisation programmes to the centre of global health discussions.
View as eBook | Download as PDF
Angle June 2012. Ambitious Europe
In this issue of Angle we focus on sharing our experiences from countries and companies in Europe. NNE Pharmaplan’s strong presence in Europe with more than a dozen offices throughout the region is part of our ambition for the future. We will continue to grow locally in Europe because we believe in working closer with our customers – in Europe as well as in the rest of the world.
View as eBook | Download as PDF
Angle April 2012. Biopharmaceuticals: Entering a new world
Going forward, biosimilars will make some treatments affordable for more patients. And biosimilars will encourage innovative pharmaceutical companies to invest in the development of new and improved treatments as well as more cost-effective manufacturing solutions for existing products – including biosimilars.
In this issue of Angle, we will take you through some of these interesting challenges and opportunities.
View as eBook | Download as PDF